Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers

Cancer Science

Volumn 102, Issue 6, 2011, Pages 1223-1227

  Mori, Seiichiro ^a   Nakao, Sari ^a   Kukimoto, Iwao ^a   Kusumoto Matsuo, Rika ^a   Kondo, Kazunari ^b   Kanda, Tadahito ^a,c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Kanto Teishin Hospital   (Japan)

^c RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NYLON; VIRUS DNA;

AMPLICON; ARTICLE; C2M GENE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS 51; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HYBRIDIZATION; L1C1 GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VIRUS GENE; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BASE SEQUENCE; CAPSID PROTEINS; CERVIX UTERI; CONSENSUS SEQUENCE; DNA PRIMERS; DNA, VIRAL; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL DISEASES;

EID: 79956195099     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01922.x     Document Type: Article

References (31)

1. Howley PM, Lowy DR. Papillomaviruses and their replication. In: Lnipe DM, Howley PM, eds. Fields Virology, Vol. 2, 4th edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2001; 2197-229.
2. Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? Int J Cancer 2004; 111: 278-85.
3. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24: S3/35-41.
4. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005; 32: S43-51.
5. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991; 82: 524-31.
6. Iwasaka T, Matsuo N, Yokoyama M, Uchiyama K, Fukuda H, Sugimori H. Prospective follow-up of Japanese women with cervical intraepithelial neoplasia and various human papillomavirus types. Int J Gynecol Obstet 1998; 62: 269-77.
7. Yoshikawa H, Nagata C, Noda K et al. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 1999; 80: 621-4.
8. Maehama T, Asato T, Kanazawa K. Prevalence of HPV infection in cervical cytology-normal women in Okinawa, Japan, as determined by a polymerase chain reaction. Int J Gynaecol Obstet 2000; 69: 175-6.
9. Maehama T, Asato T, Kanazawa K. Prevalence of human papillomavirus in cervical swabs in the Okinawa Islands, Japan. Arch Gynecol Obstet 2002; 267: 64-6.
10. Masumoto N, Fujii T, Ishikawa M et al. Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women. Br J Cancer 2003; 88: 1883-8.
11. Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 2004; 189: 1829-32.
12. Masumoto N, Fujii T, Ishikawa M et al. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients. Gynecol Oncol 2004; 94: 509-14.
13. Maehama T. Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix. Infect Dis Obstet Gynecol 2005; 13: 77-80.
14. Takakuwa K, Mitsui T, Iwashita M et al. Studies on the prevalence of human papillomavirus in pregnant women in Japan. J Perinat Med 2006; 34: 77-9.
15. Onuki M, Matsumoto K, Satoh T et al. Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci 2009; 100: 1312-6.
16. Matsumoto K, Oki A, Furuta R et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer 2010; doi.
17. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cell 1989; 7: 209-14.
18. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057-62.
19. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73.
20. Gravitt PE, Peyton CL, Alessi TQ et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-61.
21. Söderlund-Strand A, Carlson J, Dillner J. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol 2009; 47: 541-6.
22. World Health Organization, Department of Immunization, Vaccines and Biologicals. Human papillomavirus laboratory manual, 1st edn. 2009. Available from URL.
23. Mendez F, Munoz N, Posso H et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005; 192: 1158-65.
24. Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 2010; 48: 143-9.
25. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36: 3020-7.
26. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006; 44: 504-12.
27. Chan PK, Cheung TH, Tam AO et al. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 2006; 118: 243-5.
28. Rosner A, Maslenin L. Interference in PCR: transcription amplifications of mixed PVY isolates. Plant Prot Sci 2005; 41: 125-31.
29. Coutlée F, Gravitt P, Kornegay J et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 2002; 40: 902-7.
30. Klug SJ, Hukelmann M, Hollwitz B et al. Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol 2007; 79: 616-25.
31. van Doorn LJ, Quint W, Kleter B et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 2002; 40: 979-83.